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Shigella flexneri, causative agent of bacillary dysentery (shigellosis), uses a type III
secretion system (T3SS) as its primary virulence factor. The T3SS injectisome delivers
effector proteins into host cells to promote entry and create an important intracellular
niche. The injectisome’s cytoplasmic sorting platform (SP) is a critical assembly that
contributes to substrate selection and energizing secretion. The SP consists of oligomeric
Spa33 “pods” that associate with the basal body via MxiK and connect to the Spa47
ATPase via MxiN. The pods contain heterotrimers of Spa33 with one full-length copy
associated with two copies of a C-terminal domain (Spa33C). The structure of Spa33C is
known, but the precise makeup and structure of the pods in situ remains elusive. We
show here that recombinant wild-type Spa33 can be prepared as a heterotrimer that
forms distinct stable complexes with MxiK and MxiN. In two-hybrid analyses, association
of the Spa33 complex with these proteins occurs via the full-length Spa33 component.
Furthermore, these complexes each have distinct biophysical properties. Based on these
properties, new high-resolution cryo-electron tomography data and architectural
similarities between the Spa33 and flagellar FliM-FliN complexes, we provide a
preliminary model of the Spa33 heterotrimers within the SP pods. From these findings
and evolving models of SP interfaces and dynamics in the Yersinia and Salmonella T3SS,
we suggest a model for SP function in which two distinct complexes come together within
the context of the SP to contribute to form the complete pod structures during the
recruitment of T3SS secretion substrates.
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Type III secretion systems (T3SS) are used by many Gram-negative
bacterial pathogens to inject host altering proteins into the cytoplasm
of target cells (Portaliou et al., 2016; Galan andWaksman, 2018). The
Shigella flexneri T3SS apparatus (injectisome) comprises four
assemblies that work cooperatively to secrete effectors. The needle
tip complex is exposed on the bacterial surface where it can make
contact with the host cell membrane and contribute to the formation
of a translocon pore (Deane et al., 2006; Espina et al., 2006b). The
translocon and tip complex reside at the distal end of a needle that is
generated from a polymer ofMxiH (Cordes et al., 2003; Kenjale et al.,
2005). The needle is then anchored to an envelope-spanning basal
body (the injectisome core) (Blocker et al., 1999; Lunelli et al., 2020),
which is associated with a cytoplasmic sorting platform (SP) (Hu
et al., 2015). The SP contributes to substrate selection and to
energizing secretion. The SP was originally proposed as a complex
in Salmonella that included SctK, SctQ and SctL (Lara-Tejero et al.,
2011) for which the Shigella homologues are MxiK, Spa33 and
MxiN, respectively. An increasingly accepted uniform nomenclature
for the injectisome components is provided as a guide in Table 1
(Wagner and Diepold, 2020) and will be used here when referring to
all non-Shigella T3SS.
A key interface between the basal body and the SP in Shigella
is formed by interaction of the inner membrane ring (IR) protein
MxiG (SctD) with an SP adaptor protein. The cytoplasmic
forkhead associated-like (FHA-like) domain of MxiG (MxiGC)
and the SP protein MxiK (SctK) mediate this interaction
(Tachiyama et al., 2019). A feature of this interface is a switch
from the 24-fold symmetry of the IR components to the six-fold
symmetry of MxiK, which is in association with the SP “pods”.
The pods are the largest densities in the SP and comprise
heterooligomeric complexes of Spa33 (SctQ) (Hu et al., 2015;
McDowell et al., 2016). Spa33, in turn, interacts with MxiN
(SctL) and this links them to the central ATPase Spa47 (SctN)
(Supplementary Figure S1) (Hu et al., 2015; Notti et al., 2015).
Our understanding of the composition of the SP has evolved with
recent cryo-electron tomography (cryo-ET) work using minicells
derived from Shigella (Supplementary Figure S1), which are in
agreement with structures seen using similar methods for the
Salmonella injectisome (Hu et al., 2015; Hu et al., 2017).
Interestingly, deletion of mxiK or spa33 results in complete
loss of SP assembly, however, mutants in which the radial
spoke (and ATPase regulator) protein gene mxiN is deletedFrontiers in Cellular and Infection Microbiology | www.frontiersin.org 2continue to allow remnants of the pods to be viewed while
Spa47 is absent (Supplementary Figure S2) (Hu et al., 2015).
Recombinant Spa33 (expressed from the wild-type gene)
purifies as a heterotrimer comprising one copy of full-length
Spa33 and two copies of a C-terminal fragment generated via an
alternative internal translation start site (McDowell et al., 2016).
The C-terminal fragment (Spa33C) is a “surface presentation of
antigens” (SPOA) domain named for alternative forms of SctQ
from Salmonella and in Pseudomonas syringae (Fadouloglou
et al., 2004; Notti et al., 2015; Notti and Stebbins, 2016). As
described in depth for SctQ from Salmonella, full-length Spa33
possesses two SPOA domains at its C-terminus, but an internal
translation start site allows for the second of these (SPOA2) to be
expressed separately from the full-length protein (Notti et al.,
2015). SPOA domains have a significant b-structure component
and are structurally equivalent to FliN from Thermotoga
maritima, which is a component of the flagellar C-ring
(Supplementary Figure S3) (Brown et al., 2005; McDowell
et al., 2016). Interestingly, the Spa33 heterotrimer shares
significant similarity to the FliM-FliN heterotetramer (FliM-
FliN3) where the full-length Spa33 contributes its C-terminal
SPOA2 domain and the Spa33C homodimer contributes two
additional FliN-equivalent SPOA domains (Fadouloglou et al.,
2004; McDowell et al., 2016). This observation prompted the Lea
group to logically propose a model in which Spa33 forms a torus
structure resembling the flagellar C-ring (McDowell et al., 2016).
Subsequent cryo-ET imaging, however, indicated that the bulk of
the SP is actually made up of discontinuous pods described above
(Hu et al., 2015).
Diepold et al. estimated that there are approximately 22
copies of SctQ in the SP of Yersinia (Diepold et al., 2015). This
is consistent with the observation that the crystal structure of
Spa33C dimers would only occupy a small portion of the pod
densities attributed to Spa33. Based on available data, it now
appears that the injectisome pods each consist of multiple copies
of Spa33 and Spa33C. Furthermore, Diepold et al. found that
during active secretion these SctQ components are in continual
exchange between the injectisome SP and a distinct cytoplasmic
pool of these proteins (Diepold et al., 2015; Diepold et al., 2017).
The dynamics occurring within the SP ultrastructure are
considered to be important for type III secretion system
activity. Therefore, a better understanding of the structure of
the SctQ complexes within the SP should move the field closer to
understanding the mechanisms that govern injectisome function.TABLE 1 | The standardized nomenclature for the inner membrane ring (IR) and sorting platform components for injectisome components discussed here.
Organism Outer IRa Inner IR Pod and Adaptor Proteins Spokes ATPase
Standardized Nomenclatureb SctD SctJ SctQ/SctK SctL SctN
Shigella species MxiG MxiJ Spa33/MxiK MxiN Spa47
Salmonella enterica PrgH PrgK SpaO/OrgA OrgB InvC
P. aeruginosa PscD PscJ PscQ/PscK PscL PscN
Yersinia species YscD YscJ YscQ/YscK YscL YscNJune 2021 | Volume 11 | ArticleaThe outer portion of the inner membrane ring (IR) possesses a transmembrane helix that connects a periplasmic domain that assembles into a ring with 24-fold symmetry and a
cytoplasmic portion that is a smaller forkhead associated-like (FHA-like) domain.
bA standardized nomenclature has been proposed using the common name Sct (secretion and cellular translocation) for each T3SA component (Wagner and Diepold, 2020).682635
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terminal domain (SctQC) may not be required for generating a
functional injectisome (Lara-Tejero et al., 2019). Instead, it may
only stabilize full-length SctQ by occupying a site on the
protein that within the functional SP is occupied by SctL.
Bernal et al. suggested that a complex consisting of SctQ,
SctQC, SctL and SctN can be prepared, perhaps suggesting
that SctQC is a required component of the fully functional
injectisome (Bernal et al., 2019). Nevertheless, elimination of
SctQC genetically still allowed for secretion of the Salmonella
invasion proteins (Sips) and only reduced invasiveness by 50%,
which is in agreement with the work suggesting SctQC is not
essential. On the other hand, Bernal et al. did report that
elimination of the internal translation start site still allowed
for low-level production of SctQC (Bernal et al., 2019). Work
in the Shigella system suggests that Spa33C is indeed
required for forming a functional SP because a mutation that
eliminates the internal alternative translation start site to limit
expression to full-length Spa33 (Spa33FL) fails to restore
detectable secretion of translocator and effector proteins
(McDowell et al., 2016). The contrasting findings indicate a
need to better understand the actual makeup and organization
of the SP pods in Shigella. Even more recently, additional
Spa33 protein variants were identified, including a 6.5 kDa
form called Spa33CC (found to be important for injectisome
activity) and two other Spa33 variants (called Spa33N and
Spa33X) that have no obvious functions and may be
translational artifacts (Kadari et al., 2019). Although we have
also observed production of Spa33CC (unpublished
observation), it will not be considered further here since it
does not associate with the Spa33 heterotrimer.
While the Shigella and Salmonella in situ injectisomes are
similar in structure based on cryo-ET imaging (Hu et al., 2015;
Hu et al., 2017), there are differences between the two that
warrant investigating both. The functional Shigella injectisome
requires expression of wild-type spa33 and the production of
one Spa33FL and two copies of Spa33C (McDowell et al., 2016).
Moreover, we show here that the Spa33 heterotrimer forms
stable complexes with MxiK and MxiN that have distinct
biophysical behaviors in vitro. Within these complexes,
Spa33C acts to stabilize Spa33FL, which is otherwise not
soluble, and the Spa33 heterotrimer stabilizes MxiK, which
also is not otherwise soluble. Two-hybrid analyses indicate that
Spa33FL is able to associate with MxiK, but Spa33C is not,
suggesting that Spa33FL mediates formation of the Spa33-MxiK
complex. Meanwhile, it was wild-type Spa33 that was found to
purify as part of the complex with MxiK, suggesting that
Spa33C is required to stabilize this overall complex, as well.
Likewise, MxiN specifically interacted with Spa33FL according
to two-hybrid analyses but not with Spa33C, and it could
associate with the Spa33 heterotrimer to form Spa33-MxiN
complexes in vitro. Based on our ability to generate these
complexes, their biophysical properties and old and new
higher-resolution cryo-ET images, we propose that these two
Spa33-containing complexes have critical discrete roles in
active type III secretion.Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 3MATERIALS AND METHODS
Materials and Strains
S. flexneri 5a (M90T) was provided from J. Rohde (Dalhousie
University, Halifax, NC, Canada). Shigella mxiK and mxiN null
strains were from A. Allaoui (Université Libre de Bruxelles,
Bruxelles, Belgium) the and spa33 null strain was from C.
Lesser (Massachusetts General Hospital, Cambridge,
Massachusetts, USA). Mutant strains were grown at 37°C on
trypticase soy agar (TSA) plates containing Congo red and then
used to inoculate trypticase soy broth (TSB) containing 50 µg/mL
kanamycin to select for virulence plasmid-harboring null strains.
Ampicillin (100 µg/mL) was added to select wild-type mxiK,
mxiN, spa33, or their mutant genes in the pWPsf4 expression
plasmid. To generate minicells, wild-type S. flexneri was
transformed with pBS58, which is a low-copy number plasmid
encoding the spectinomycin-resistance gene. pBS58
continuously expresses the E. coli genes ftsQ, ftsA, and ftsZ,
which causes abnormal cell division to produce Shigellaminicells
(Bi and Lutkenhaus, 1990; Hu et al., 2015; Farley et al., 2016). To
produce Shigella minicells, spectinomycin (100 µg/mL) was
added into trypticase soy broth (TSB) to grow the strain for
overnight. A mL of this overnight culture was added into 100 mL
of fresh TSB with spectinomycin (100 µg/mL) and grown at 37°C
to an absorbance of 1.0 at 600 nm (A600) (Hu et al., 2015;
Tachiyama et al., 2019). To enrich for minicells, the culture was
centrifuged at 1000 × g for 5 min to remove the large cells, and
the supernatant fraction was further centrifuged at 20,000 × g for
10 min to collect the minicells for subsequent cryo-ET imaging of
the SP pods.
Protein Expression
To prepare expression vectors with wild-type spa33, spa33C,
spa33FL (lacking the internal translation start site), mxiK or
mxiN, each gene from S. flexneri was amplified using PCR.
PCR products were purified and inserted into the pT7HMT
expression vector (Geisbrecht et al., 2006; Tachiyama et al.,
2019), which encodes His6-tag with TEV protease cleavage site
at N-terminal side of the cloning site and a kanamycin resistance
gene. To generate E. coli strains for protein expression, these
recombinant plasmids were introduced into Tuner (DE3) cells
(Novagen). For co-expression of mxiK and spa33, the latter was
inserted into multiple cloning site two in pACYCDuet™
(Novagen). E. coli Tuner(DE3) cells were then transformed
with both mxiK in pT7HMT and spa33 in pACYCDuet™. To
induce protein expression, E. coli strains with recombinant
pT7HMT vector were inoculated into LB with kanamycin (50
µg/mL) and grown overnight. The overnight bacterial culture
was used to inoculate a larger volume of LB with the antibiotic.
When the A600 reached 0.6, the cultures were induced with 0.5
mM isopropyl b-D-1-thiogalactopyranoside (IPTG). The culture
was then incubated at 16°C overnight. MxiK and Spa33
production was carried out the same way except that Terrific
Broth (TB) with kanamycin and chloramphenicol (34 µg/mL)
was used for the large volume culture with induction started at an
A600 of 1.0.June 2021 | Volume 11 | Article 682635
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The cells expressing the protein of interest were harvested by
centrifugation at 4000 rpm for 10 min at 4°C. The cell pellet was
suspended in immobilized metal affinity chromatography
(IMAC) binding buffer (5 mM imidazole, 0.5 M NaCl, 20 mM
Tris) pH 7.5. The lysate was prepared using a microfluidizer at
15,000 psi for three cycles and clarified by centrifugation at
10,000 rpm for 30 min at 4°C. The clarified supernatant was
applied to a Ni2+-charged IMAC column with chromatography
carried out on an AKTA™ purification system (GE Healthcare,
Chicago, IL). The loaded column was washed with additional
IMAC binding buffer and then elution carried out using an
elution buffer (0.5 M imidazole, 0.5 M NaCl, and 20mM Tris, pH
7.5). The His6 tag was removed using TEV protease after
overnight dialysis in IMAC binding buffer. The protein was
then applied to a second Ni-IMAC column and the flow-through
collected, concentrated and buffer exchanged into 20 mM Tris,
200 mM NaCl, pH 7.5 prior to loading onto an equilibrated
Superdex 200 pg (GE) for size exclusion chromatography (SEC).
All fractions were analyzed by SDS-PAGE. SEC was also used to
purify Spa33-MxiN complexes after mixing the proteins after
each had been purified separately. TheMxiN, Spa33-MxiK and
Spa33-MxiN samples were made to 10% (v/v) glycerol.
Contact-Mediated Hemolysis
To test for secretion and translocon formation, contact-mediated
hemolysis was performed for each Shigella mutant strain. Each
strain was grown on a trypticase soy agar (TSA) plate containing
Congo-red (Picking et al., 2005; Tachiyama et al., 2019). Isolated
colonies were inoculated into TSB for growth at 37°C until mid-
log phase with the appropriate antibiotics added for selection. A 10
mL aliquot of each culture was centrifuged at 4,000 rpm for 10min
at 30°C and the pellet was resuspended in 10 mM phosphate, pH
7.4 containing 150 mM NaCl (PBS). The PBS was adjusted to give
equal concentrations of bacteria in each case based on the A600. To
prepare red blood cells, defibrinated sheep red blood cells
(Colorado Serum, Co.) were washed with PBS and resuspended
into 3 mL PBS. Then 50 µL of the resuspended bacteria were
added into 50 µL of washed red blood cells in a 96-well plate. The
plate was centrifuged at 3,500 rpm for 15 min at 30°C to force
Shigella contact with red blood cells. The plate was then incubated
at 37°C for an hour. The cell mixtures were then vigorously
resuspended with 100 µL cold PBS and centrifuged at 3,500 rpm
for 15 min at 10°C. The supernatants were then transferred into a
new 96-well plate and the amount of released hemoglobin was
measured based on the A545. The absorbance was used to calculate
relative hemolysis for each strain after comparison to a control for
negative hemolysis (incubation in PBS) and a control for positive
(complete) hemolysis (incubation in water).
Far-UV Circular Dichroism
(CD) Spectroscopy
The secondary structure of recombinant proteins and their
complexes were analyzed by CD spectroscopy (Espina et al.,
2006a; Birket et al., 2007) using a JASCO model J-1500 CD
spectropolarimeter (Jasco Inc., Easton, MD). Samples wereFrontiers in Cellular and Infection Microbiology | www.frontiersin.org 4prepared in 20 mM Tris, pH 7.0, 200 mM NaCl, 5.0% glycerol
and the same buffer was used for blank subtraction. For MxiN,
tris(2-carboxyethyl)phosphine (TCEP) was added to the buffer to
a final concentration of 1 mM. For Spa33 and Spa33C, PBS was
used as the buffer. To obtain CD spectra, ellipticities between 190
and 260 nm from each protein sample in 0.1 cm path length
quartz cuvettes were obtained at 10°C. Molar ellipticities were
then calculated based on protein concentration, molecular
weight, and residue numbers. To monitor thermal stability, the
molar ellipticity at 222 nm (a minimum seen for proteins having
an a-helical component) was monitored every 2.5°C with
increasing temperature from 10 to 90°C at a ramp rate of
15°C/h rate. The molar ellipticity was then plotted as a
function of temperature to provide a thermal unfolding curve.
Thermal transition points or unfolding midpoints (Tm) was
determined using Prism software from GraphPad.
Cryo-ET Data Collection and
Tomogram Reconstruction
A Polara G2 electron microscope (FEI Company) equipped with
a field emission gun and a Direct Detection Camera (K2 summit,
Gatan) was used to image frozen-hydrate minicells from the
wild-type Shigella strain at -170°C. The microscope was operated
at 300 kV, with a pixel size of 2.6 Å at the specimen level. The
single-axis tilt series was collected at about 5 µm defocus using
SerialEM software (Mastronarde, 2005) and with a cumulative
dose of ~50 e/Å2 distributed over 35 stacks covering an angle
range of -51° to 51° with 3° angle step.
Motioncorr2 (Zheng et al., 2017) was used to do drift correction
for each image stack. Then, the tilt series were aligned by IMOD
(Kremer et al., 1996), and weighted back-projection (WBP) or
Simultaneous Iterative Reconstruction Technique (SIRT) was used
to reconstruct the tomograms by Tomo3D software (Agulleiro and
Fernandez, 2015). A total of 922 tomograms were reconstructed for
the wild-type Shigella minicell sample.
Sub-Tomogram Averaging
A total of 4,488 injectisome particles from wild-type Shigella
were manually picked from the SIRT reconstructed tomograms
as previously described (Hu et al., 2015). The particle positions
were then used to extract the sub-tomograms from the 1×1×1
binned WBP reconstructed tomograms. I3 software (Winkler,
2007; Winkler et al., 2009) was used for the sub-tomogram
averaging. 4×4×4 binned sub-tomograms were used for an initial
alignment and 3D classification, and then 2×2×2 (or 1×1×1)
binned sub-tomograms were used for refinement. To improve
the resolution of the pod structure, a single pod region in the
subtomogram average (the green arrow region in Figure 7A) was
extracted for additional focused refinement processes.
3D Visualization and Molecular Modeling
The SP of the overall T3SA (see Figure 7A) and the refined single
pod structures were used to create 3D surface rendering images
of the sub-tomogram averaging using UCSF Chimera (Pettersen
et al., 2004) and ChimeraX (Goddard et al., 2018) software. For
the molecular model, the crystal structure of SctK fromJune 2021 | Volume 11 | Article 682635
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MxiK position in the refined pod rendering image using “fit in
map” in UCSF Chimera (Pettersen et al., 2004; Hu et al., 2015;
Tachiyama et al., 2019; Muthuramalingam et al., 2020). Three
FliN (PDB: 1YAB) (Supplementary Figure S3) and a FliM
(PDB: 2HP7) (see Supplementary Figure S14) crystal
structures from Thermotoga maritima were used to generate a
Spa33 heterotrimer model based on a FliN and FliM complex
model from the flagellar C-ring (Carroll et al., 2020). Two copies
of this model could fit into the bottom part of Spa33 region using
the “fit in map’ in UCSF Chimera software (Pettersen et al.,
2004). The single pod surface rendering image was then fit back
into six pod regions in the 3D surface rendering image of the SP
(see Figure 7).
Data and Software Accessibility
The pod cage structure and the refined images have been
deposited in the EM Data Bank (EMD-23440).
Bacterial Adenylate Cyclase Two-Hybrid
(BACTH) Assay
A BACTH assay was used to assess possible interactions between
the different SP proteins (MxiK, MxiN and Spa33 and their
mutants) in an in vivo-like environment (Tachiyama et al., 2019).
CyaA subdomain (T25 and T18) fusion proteins were prepared
by cloning the proteins of interest from wild-type bacteria. The
subdomains were fused to either the N- or C-terminus of the
potential interacting protein. The pKT25 expression vector fuses
the T25 subdomain to the protein’s N-terminus while the
pKNT25 vector fuses the T25 subdomain to the C-terminal
end of the protein. The same is achieved for fusion of the T18
subunit using the pUT18 or pUT18C vectors, which fuses the
T18 unit to the N- and C-terminus of the protein.
Two compatible plasmids containing the gene fusions of
interest were used to co-transform the cyaA- E. coli strain,
BTH101. BTH101 was co-transformed with empty plasmids
was used for the negative control and the strain was co-
transformed with plasmids encoding leucine zipper binding
partners for the positive control. Individual colonies were
selected on LB plates containing ampicillin and kanamycin and
these were inoculated into LB broth containing these antibiotics
and 0.5 mM IPTG. The bacteria were grown at 30°C overnight.
The overnight bacterial cultures were washed three times with
M63 minimum medium and 2 µL was spotted onto indicator
plates. Indicator plates could be: a) LB agar plates with
ampicillin, kanamycin, 40 µg/mL X-Gal and 0.5 mM IPTG; b)
MacConkey agar plates with ampicillin, kanamycin and 1.0%
(w/v) maltose; or c) M63 plates with ampicillin, kanamycin, 40
µg/mL X-Gal and 0.5 mM IPTG. These plates were incubated at
30°C for four to five days and color changes over time were
compared with that seen for the controls.
Testing the MxiN-Spa33 Interaction Using
Size-Exclusion Chromatography (SEC)
Purified MxiN and Spa33 were both dialyzed into 20 mM
Tris, pH 7.5, 150 mM NaCl with 10% glycerol (v/v) for SEC.Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 5The MxiN and Spa33 were combined with an excess of MxiN
and the mixture was concentrated to a final volume of 2 mL for
injection onto a Hi Load 26/600 Superdex 200 pg column (GE
Healthcare Life Sciences). The protein absorbance at 280 nm was
monitored to detect protein elution on an AKTA system (GE
Healthcare Life Sciences). The eluted fractions were collected for
SDS-PAGE analysis.
Biolayer Interferometry (BLI)
The binding of MxiN to the wild-type Spa33 was assessed by
biolayer interferometry (BLI) as described elsewhere (Barta et al.,
2017). Purified His6-tagged MxiN was dialyzed into PBS with
10% glycerol, 0.01% BSA and 0.002% Tween 20 (BLI buffer). The
MxiN was then immobilized onto a Ni-NTA biosensor tip and
washed with BLI buffer for 5 min to remove non-immobilized
protein. Once a baseline signal was established, the sensors with
immobilized protein were immersed into a solution containing
untagged Spa33, which was prepared and adjusted to 400, 200,
100, 50, 25 and 12.5 µg/mL. The Octet RED96 system (FortéBIO,
Inc., Freemont, CA) was then used to monitor the binding of
Spa33 to MxiN that had been immobilized onto a Ni-NTA
biosensor tip. The binding of Spa33 at each concentration to
the immobilized MxiN was measured in real time to obtain
the association rate. The biosensor tips were then placed into
BLI buffer lacking Spa33 to measure the dissociation rate.
All steps were performed at 25°C. Real-time data were
analyzed using Octet Software version 8.2 (ForteBio). Binding
kinetics (association and dissociation) as well as steady-state
equilibrium concentrations were fitted using a 1:1 Langmuir
binding model. Background correction was done by subtracting
the data from ligand-loaded biosensor that had been incubated
without analyte (Spa33). All steps were carried out with constant
shaking at 1000 rpm and each measurement was performed in
triplicate with an association time of 300 s followed by 300 s
dissociation. The sensorgrams from the experiment were fitted
with 1:1 binding equations available for interaction from a global
curve fit using Data Analysis software 7.1.0.36 (ForteBio) (Barta
et al., 2017).
Dynamic Light Scattering (DLS)
The effect that Spa33 inclusion into complexes with MxiK and
MxiN has on particle size and surface charge was determined
using dynamic light scattering (DLS). DLS measurements were
made on a Malvern ZetaSizer Ultra using a quartz cuvette with a
1-cm path length. Backscattering was detected at an angle of
174.7 degrees, with each measurement performed in triplicate.
Size distributions were calculated using the ZS Xplorer software
(Malvern). The same instrument was used to determine the zeta-
potential for each protein and protein complex.RESULTS
Interactions Within the Spa33 Heterotrimer
When Spa33 is expressed in E. coli, it readily purifies as a
complex containing one full-length Spa33 (Spa33FL) with twoJune 2021 | Volume 11 | Article 682635
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translation initiation site (Supplementary Figure S4). When
the alternative start site is mutated to prevent initiation of the
internal translation event, giving only Spa33FL, the protein could
not be stably expressed and purified from E. coli, due to the fact
that it is insoluble and sequestered to inclusion bodies. This is in
contrast to expressing a gene that allowed for expression of only
Spa33C, which is then easily purified as an apparent homodimer
(Supplementary Figure S4). Spa33C was previously used to
obtain a crystal structure for this SPOA domain (McDowell
et al., 2016). The fact that Spa33 forms an oligomer is further
supported by data from a bacterial adenylate cyclase two-hybrid
(BACTH) assay where both the bait and prey plasmids contained
the wild-type spa33 gene (Table 2 and Supplementary Figure
S5, top). The results with wild-type Spa33 are somewhat
complicated since when the two adenylate cyclase domains are
placed at the Sp33 N-terminus an interaction was observed. This
could suggest that multiple Spa33 complexes were forming a
higher order complex. We thus felt that it was imperative to look
at interactions involving only Spa33FL, only Spa33C, and Spa33FL
plus Spa33C.
When Spa33FL was used in the same two-hybrid assay, no
interaction was detected for any of the eight fusion permutations
with the T18 and T25 fragments of the adenylate cyclase (Table 2
and Supplementary Figure S5, bottom). In contrast, when
Spa33C was used in the same assay, a clear interaction was
again observed (Table 2 and Supplementary Figure S6). It is
worth noting that not every fusion permutation between the
Spa33C binding pairs gave a positive reaction, but this is not
surprising given that the interaction between the binding
partners must orient the T18 and T25 fragments of the
CyaA adenylate cyclase domains properly for activity to be
restored (Supplementary Figure S7). Perhaps more surprising
was the observation that all combinations of wild-type
Spa33 were positive for interactions in the BACTH system
(Supplementary Figure S5). Finally, when Spa33FL was used
in the same two-hybrid analysis with Spa33C, an interaction was
observed, though not for every fusion permutation, which is
consistent for what was seen for the Spa33C-Spa33C interaction
(Table 2 and Supplementary Figure S8). These data confirm
what is currently believed to occur with respect to the
interactions within the Spa33 heterotrimer. However, they also
show that interactions within the Spa33-containing pods of theFrontiers in Cellular and Infection Microbiology | www.frontiersin.org 6SP do not arise from Spa33FL-Spa33FL interactions, at least not in
the absence of Spa33C.
It was previously reported that neither Spa33FL nor Spa33C
alone could restore the secretion of Ipa proteins when expressed
in a Shigella spa33 null strain (McDowell et al., 2016). In
agreement with this prior observation, neither of these forms of
Spa33 alone could support contact-mediated hemolysis, although
a small amount of residual hemolytic activity was observed for
Spa33FL (Figure 1). The reason for the low level of hemolysis for
Spa33FL was not entirely clear. It is possible that it could be related
to the reported observation by the Lara-Tejero et al. that the
Spa33C homologue from Salmonella (SctQC) is not required for
secretion of translocator proteins or for cellular invasion (Lara-
Tejero et al., 2019) and that it merely contributes to stabilization
of SctQFL (the full-length form). They also suggested that SctQC
contributed to the stabilization of other SP components (SctK and
SctL). Indeed, Spa33C is required for stabilization of Spa33FL since
in its absence Spa33FL is insoluble, however, the very minor
degree of restoration of contact-mediated hemolysis for Shigella
expressing Spa33FL is not at a level considered here to indicate it
gives rise to an active injectisome. This is consistent with our
observation that when the contact-hemolysis assay is allowed to
incubate for long periods of time, the level of hemoglobin release
gradually increases (unpublished observation). Thus, there may
be degradation of components (i.e. Spa33FL) that allow for
undetectable amounts of Spa33C to accumulate and allow
residual T3SS activity to be seen as a function of time. This
would fit with observations by Bernal et al. who found that SctQFL
gave rise to a minor population of SctQC (Bernal et al., 2019),
however, even in that report there was a 50% restoration ofTABLE 2 | Specific Spa33 interactions can be identified by two-hybrid a analysis.
Protein species Wild-type Spa33 Spa33FL Spa33C
Wild-type Spa33 + ND ND
Spa33FL ND – +
Spa33C ND + +aBacterial adenylate cyclase two-hybrid (BACTH) analysis was used to determine specific
interactions between the different variants of Spa33 known to exist within the SP pods. A
positive interaction was determined based on X-gal cleavage on LB agar plates and
maltose utilization on MacConkey agar plates for at least one of eight possible
combinations of the T18 and T25 domains of cya fused with Spa33, Spa33FL or
Spa33C. A positive interaction is denoted with a + and a negative interaction is denoted
with a -. ND indicates that this combination was not tested.FIGURE 1 | Contact-mediated hemolysis shows that Spa33FL and Spa33C
are not active when expressed in a Shigella spa33 null mutant. To test the
type III secretion activities of the Spa33 variants in vivo, contact-mediated
hemolysis was used to measure of translocon formation. Spa33FL did restore
a minor amount of hemolysis activity (about 8%), however, Spa33C was
completely inactive. The level of injectisome activity seen for Spa33FL was far
below that seen for SctQFL in Salmonella. Statistical differences between wild-
type Spa33 (Spa33WT) and other samples (in triplicate) were assessed using
one-way ANOVA with Spa33FL, Spa33C and the spa33 null all with p <0.005)
and error bars depict mean ± SD.June 2021 | Volume 11 | Article 682635
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level of contact-mediated hemolysis for Spa33FL (Figure 1).
Biophysical Analysis of Wild-Type Spa33
and Spa33C Using Circular Dichroism
(CD) Spectroscopy
Circular dichroism (CD) spectroscopy was used to compare the
secondary structure properties of the purified Spa33 heterotrimer
and Spa33C homodimer. Both complexes possess a dominant b-
structure component with only a minor amount of a-helical
structure in each (Figure 2). By monitoring the CD signal 222
nm as a function of temperature, we found that Spa33C was
highly stable with an unfolding transition midpoint (Tm) of 65°C
(Figure 2B and Table 3). Meanwhile, the wild-type Spa33 had a
Tm of 62°C. Because Spa33FL could not be purified as a
recombinant protein, Spa33C clearly had a significant
solubilizing effect on it. In this respect, Spa33C has a similar
effect on Spa33FL stability as does SctQC on SctQFL in Salmonella
(Lara-Tejero et al., 2019).
The Formation of a Spa33 Complex
With MxiK
We have shown that MxiK interacts with wild-type Spa33 in the
in situ injectisome and this was confirmed by two-hybrid
analysis (Tachiyama et al., 2019). As a follow up, we carried
out BACTH analyses using MxiK with wild-type Spa33, Spa33FL
and Spa33C. While we know that MxiK binds to wild-type Spa33,
it has not been shown whether this interaction occurs through
Spa33FL or Spa33C (summarized in Table 4). Based on two-
hybrid analysis, we found that MxiK was able to interact withA
B
FIGURE 2 | Circular dichroism (CD) spectra and thermal unfolding for wild-type Spa33 and Spa33C. CD spectroscopy was used to analyze the secondary structure
content and thermal stabilities of wild-type Spa33 and Spa33C. (A) The CD spectrum of wild-type Spa33 shows a negative peak at 208 nm with a modest shoulder
at 222 nm (left). This spectrum is indicative of a significant amount of b-structure. To determine the Tm for wild-type Spa33, the molar ellipticity at 222 nm was
monitored as a function of temperature. Based on the large transition observed (right) the Tm was found to be 61.88°C. (B) The CD spectrum of Spa33C also shows
more dominant 208 nm minimum suggesting a dominant b-structure component (left). Based on the thermal unfolding curve for Spa33C (right) the Tm was







Spa33 (wild-type) 61.88 13.4 ± 0.43 -8.87 ± 1.09
Spa33C 65.12 6.09 ± 0.11 -6.16 ± 1.44
Spa33/MxiK 52.46 10.2 ± 0.66 -7.25 ± 0.21
MxiN 36.63 9.85 ± 0.38 -0.28 ± 0.20
Spa33/MxiN 38.99 18.5 ± 0.96 -4.95 ± 0.82June 2021 | VolumeaUnfolding temperature (Tm) was determined as the midpoint of the thermal transition
seen at 222nm using CD spectroscopy. In all cases, the R2 was >0.98.
bDynamic light scattering and zeta-potential measurements were carried out on a
Zetasizer Nano (Malvern Instruments) at room temperature in PBS.TABLE 4 | Interactions of MxiK and MxiN with Spa33 and the individual
components of the Spa33 complex.
Protein 1 Protein 2 BACTH Resulta
Wild-type Spa33 MxiK +
Spa33FL MxiK +
Spa33C MxiK –




MxiN MxiN +11aBacterial adenylate cyclase two-hybrid (BACTH) analysis was used to determine specific
interactions between the Spa33 components known to exist within the SP pods and MxiN
and MxiN as determined by BACTH analyses and shown in the Supplementary
Materials. As in Table 2, a positive reaction for at least one of eight possible
combinations of the T18 and T25 domains was considered to give a positive interaction
for the pair. MxiK and MxiN were also tested for their ability to interact with themselves.| Article 682635
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Spa33C (Supplementary Figure S9). Whether this interaction
involves the Spa33 N-terminal domain or the SPOA1-SPOA2
domains of Spa33FL is not yet clear. In parallel experiments,
we co-expressed wild-type spa33 and mxiK in E. coli and found
that the Spa33 heterotrimer could be co-purified as a complex
with MxiK possessing an N-terminal His6-tag using IMAC
followed by size-exclusion chromatography (Figure 3 and
Supplementary Figure S10). The fact that MxiK is part of this
complex while it cannot be stably purified as a soluble protein on
its own suggests a stabilizing, or minimally a solubilizing, effect
for the Spa33 heterotrimer on MxiK.
When the CD spectrum of the Spa33-MxiK complex was
obtained, it indicated the presence of both a-helical and b-
strand components. This is consistent with contributions made
to secondary structure by both components of the complexFrontiers in Cellular and Infection Microbiology | www.frontiersin.org 8(Figure 4). We know that Spa33 is rich in b-structure and the
crystal structure and CD spectrum of the MxiK homologue SctK
from P. aeruginosa show that it is rich in a-helical structure
(Muthuramalingam et al., 2020). When the signal at 222 nm was
followed as a function of temperature, the complex showed a
single unfolding transition at 52°C though there may be a second
minor transition occurring at about 60°C (Figure 4 and Table 3).
The main transition point or Tm is below that observed for the
Spa33 heterotrimer, presumably because of structural
rearrangements in Spa33 that occur upon complex formation
that causes the complex to behave as a single entity with regard to
thermal stability. This said, it can’t be ruled out that the minor
second transition could be due to some of the Spa33 heterotrimer
or Spa33C homodimer escaping in a folded state during the first
transition to later unfold at its characteristic Tm. The relative size
of this second transition, however, is consistent with this only
represented a small subpopulation of the Spa33 present in the
original Spa33-MxiK complex. Therefore, because a single
dominant Tm is observed and MxiK cannot be prepared as a
recombinant protein by itself, the data support the proposal that
the Spa33-MxiK complex mostly behaves as a single unit
consisting of Spa33FL, Spa33C and MxiK. Although not directly
applicable here, MxiK can be purified in small amounts with a C-
terminal T4L genetically fused to it (MxiK-T4L-C) and this fusion
retains activity when expressed in a Shigella mxiK null mutant
(Tachiyama et al., 2019). This purified chimera has a Tm of about
39°C, which compares well with the Tm of SctK P. aeruginosa,
which is 40°C (Muthuramalingam et al., 2020). Thus, although the
complex has a thermal unfolding transition below that of the
Spa33 heterotrimer, it does have a significant stabilizing effect on
MxiK. Likewise, the fact that a second transition is not observed
supports the idea that it behaves as a single stably folded unit.Assembly of a Spa33 Complex With
MxiN In Vitro
MxiN forms the radial spokes that connect the Spa33 pods of the SP
with the hubwhich is a hexamer of the Spa47ATPase.MxiN forms a
dimer and interacts with wild-type Spa33 as observed in two-hybrid
analyses (Tachiyama et al., 2019).When the same two-hybrid system
was used to explore MxiN interactions with the two components ofFIGURE 3 | SDS-PAGE analysis for all purified complexes containing Spa33.
From the left, wild-type Spa33, Spa33C, MxiN, a MxiN mutant with all Cys
residues removed to allow future crystallography screens (fully active in vivo),
the MxiN-Spa33 complex formed in vitro and the MxiK-Spa33 complex
purified after co-expression in E. coli. The Spa33C (second lane) is slightly
larger than the same component in the other lanes because it still possesses
an N-terminal His6-tag. Recombinant Spa33
FL and MxiK alone are not soluble
and could not be purified.A B
FIGURE 4 | CD spectrum of the wild-type Spa33-MxiK complex. (A) The secondary structure of the Spa33-MxiK complex shows a greater a-helical character than
the Spa33 heterotrimer alone. (B) To determine thermal stability, molar ellipticity at 222 nm was monitored as a function of temperature. Based on the large thermal
transition observed, the complex had a Tm of approximately 52.46°C. This Tm is lower than that of wild-type Spa33 (62°C) and higher than that of the chimera
MxiK-T4L-C (39°C), suggesting that the Spa33 interaction enhances MxiK solubility and thermal stability. R2 = 0.99.June 2021 | Volume 11 | Article 682635
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interact with Spa33FL, but not with Spa33C, which is the same result
that was observed for MxiK (Supplementary Figure S9). This is an
interesting observation in that it suggests that two proteins found at
distant sites within the SP are able to interact with the same
component, Spa33FL, within the Spa33 heterotrimer. Nevertheless,
this does not rule out the possibility that one or both proteins interact
with the two SPOAdomains of the Spa33 heterotrimer since Spa33FL
contains both a SPOA1 and a SPOA2 domain, much like what was
described for Salmonella SctQ (Notti et al., 2015; McDowell et al.,
2016). In linewith this,Notti et al. were able to solve the structure of a
complex consisting of the two SPOAdomains from Salmonella SctQ
with a fragment of SctL (MxiNhomologue) (Notti et al., 2015). Thus,
it is interesting that our two-hybrid results did not reveal an
interaction with the Spa33C dimer. Perhaps this is because this
dimer is generated from two copies of SPOA2 rather than a hybrid
SPOA1/SPOA2 structure.
Unlike MxiK, MxiN can be purified as a recombinant protein
and when its CD spectrum is obtained, it is clearly rich in a-helical
structure with a thermal unfolding transition at 36°C, which agrees
with the value reported by others (Figure 5A and Table 3) (Case
and Dickenson, 2018). When purified MxiN and Spa33 were mixed
(with MxiN being in excess) and the resulting complexes separated
by size-exclusion chromatography, MxiN was found to purify in
two populations. In addition to MxiN alone (which eluted as the
smaller of two eluting peaks of protein by SEC), MxiN also co-
purified with the Spa33 complex (Figure 3 and Supplementary
Figure S11). As with MxiK-Spa33, the CD spectrum of the Spa33-
MxiN complex was a combination of a-helical structure
(contributed by MxiN) and b-structure (contributed by Spa33).Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 9When the CD signal at 222 nm was monitored as a function of
temperature, the Tm of the major transition was found to be 39°C
(Figure 5B and Table 3), indicating that Spa33 has at least a minor
stabilizing effect on MxiN. However, a second transition at 62°C
suggests that a minor population of the MxiK-Spa33 complex, this
complex may dissociate at the lower transition temperature with the
freed MxiN then unfolding with what appears to be a slightly higher
Tm than the MxiN alone. The second transition fairly accurately
reflects the thermal unfolding reported above for the stable Spa33
heterotrimer (~60°C). This prompted us to assess the strength of the
MxiN-Spa33 interaction using biolayer interferometry (BLI). MxiN
possessing an N-terminal His6-tag was immobilized to BLI sensors
via bound Ni2+ to allow for monitoring the association and
dissociation of the wild-type Spa33 heterotrimer using BLI
(Figure 6 and Supplementary Figure S12). From these data, an
equilibrium dissociation constant (KD) of 0.55 µM was obtained,
suggesting a specific and moderately strong interaction was
occurring between them.
Examination of the Spa33-Containing
Complexes by Dynamic Light
Scattering (DLS)
From the CD data on the Spa33-containing complexes and
individual proteins presented above, a great deal of
information can be obtained regarding secondary structure
content and thermal stability. To begin putting these data into
context regarding the solution properties for these proteins and
complexes, we carried out dynamic light scattering (DLS)
studies. DLS allows us to determine the relative sizes of the
proteins and their complexes, along with ascertaining theA
B
FIGURE 5 | CD spectra from MxiN and the Spa33-MxiN complex. The secondary structures and thermal stabilities of MxiN and its complex with the wild-type Spa33
heterotrimer were analyzed by CD spectroscopy. (A) The CD spectrum of MxiN alone shows two minima that indicate a rich a-helical structure (left). The thermal
stability for MxiN was determined by plotting the molar ellipticity at 222 nm as a function of temperature. A single transition was observed giving a Tm value of 36.63°C
(right). (B) The CD spectrum for the MxiN-Spa33 complex also had two minima with the stronger minimum at 208 nm, indicating a greater b-structure content than for
MxiN alone (left). The thermal stability of the complex was tested by monitoring the molar ellipticity at 222 with increasing temperature. The complex had a major
transition with a Tm value of 38.99°C, however, a minor second transition was seen at about 60°C (right). R2 values for these unfolding curves was >0.985.June 2021 | Volume 11 | Article 682635
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also lets us determine whether the complexes are of discrete sizes
or are able to nonspecifically form larger species. Furthermore,
we obtained the zeta-potential in each case to determine the
effect of complex formation on the electrical potential of the
particles being examined. As expected, Spa33C is smaller than
the wild-type Spa33 heterotrimer (Table 3) with hydrodynamic
diameters (Dh) of 6 and 13 nm, respectively. The size of the
Spa33 complex is more than twice the size of the Spa33C dimer,
which is consistent with the compared masses of the two.
Spa33FL has been reported to be 35.6 kDa and each Spa33C
was reported to be 11.6 kDa based on mass spectrometry analysis
(McDowell et al., 2016). This means the heterotrimer would have
a mass close to 58.8 kDa relative to the Spa33C dimer’s mass of
23.2 kDa. Nevertheless, the Dh of the heterotrimer is smaller
than what might be expected for the entire pod structure based
on previous reports (Hu et al., 2015). This is consistent with there
being multiple copies of Spa33 or the Spa33-containing
complexes within each pod as has been suggested by others
(Diepold et al., 2015; McDowell et al., 2016).
Interestingly, the Spa33-MxiK complex has a Dh of 10 nm,
which is smaller than that of the Spa33 heterotrimer (Table 3),
however, the purified Spa33-MxiK complex has all three of the
expected components (Spa33FL, Spa33C and MxiK) present
(Figure 3). Furthermore, the Spa33-MxiK complex has a
dominant transition for thermal unfolding (Figure 4) and this
Tm is distinct from that shown for the Spa33 heterotrimer. This
suggests that much of the Spa33-MxiK complex acts as a single
entity. The absence of multiple complex forms is also evident from
the DLS scans when either particle numbers (Supplementary
Figure S13) or intensity (not shown) are examined. This alsoFrontiers in Cellular and Infection Microbiology | www.frontiersin.org 10suggests that the Spa33 component undergoes a significant
conformational change when in a complex with MxiK and that
the overall particle has a more compact globular structure than the
elongated Spa33 heterotrimer. The Dh for MxiK could not be
determined because this protein is not soluble on its own in
solution and could not be purified. Nevertheless, initial reports of
the interface between MxiK and the Spa33 pods using cryo-ET
imaging suggest an intimate interaction between the two
(Tachiyama et al., 2019).
In contrast to MxiK, MxiN can be purified and it was found to
have a Dh of almost 10 nm, and this is consistent with its ability
to form dimers that become the elongated spokes connecting the
pods with Spa47 (Hu et al., 2015). When incubated with Spa33 in
vitro, the resulting complex has a Dh of 18.5 nm and this is what
might be expected following the association of the two structures
(Table 3). This behavior is distinct from that of the Spa33-MxiK
complex, but like the Spa33-MxiK complex there is single-sized
species that is formed (Supplementary Figure S13). From the
two-hybrid, CD and DLS data, we propose that Spa33 forms two
distinct complexes that are stable in solution, one incorporating
MxiK and one incorporating MxiN. In each of these complexes,
it appears that the interaction with Spa33 occurs through the
Spa33FL moiety. Whether this means that the interactions occur
through the N-terminal portion of Spa33 is not yet clear,
however, Spa33C alone has not been found to be directly
responsible for the protein-protein interactions giving rise to
these complexes though it does contribute to their stabilization.
In addition to Dh, we monitored the surface charge properties
(zeta-potential) of these proteins and their complexes. Spa33 and
Spa33C both have a negative surface electric potential (Spa33 =
-8.87 nV) while MxiN has near neutral surface charge. The fact
that the Spa33-MxiN complex has a zeta-potential of -5 mV
suggests that this interaction masks some of the surface electric
potential of Spa33. In contrast, the complex with MxiK only
reduces the negative zeta-potential of Spa33 by about 1.5 mV.
While we do not know the zeta-potential of MxiK alone, this
suggests that there are significant differences in how it interacts
with Spa33 in comparison to MxiN.
Visualization of the Sorting Platform Pods
by Cryo-Electron Tomography
(cryo-ET) Imaging
Bzymek et al. first described the independent expression of a
SctQ C-terminal domain in Yersinia (Bzymek et al., 2012). Notti
et al. then identified SPOA domains and described their
relationship to flagellar FliN in their work in the Salmonella
system (Notti et al., 2015). For the Shigella system, the two SP
structures that have been solved thus far include the SPOA
domain of Spa33, which forms a dimer (the Spa33C homodimer)
(McDowell et al., 2016) and the Spa47 ATPase (Burgess et al.,
2016). While MxiK and MxiN have not had their high-resolution
structures solved. Our group recently reported the crystal
structure of the MxiK homologue from P. aeruginosa, SctK
(Muthuramalingam et al., 2020). The latter has a unique fold
and is the first structure solved for any protein in the SctK family.
No structures are available for the virulence-related T3SS Spa33/FIGURE 6 | Quantification of the in vitro binding of Spa33 to MxiN using
biolayer interferometry (BLI). MxiN with an N-terminal His6-tag was
immobilized to sensor tips to measure its ability to bind to wild-type Spa33
heterotrimers. The tips were immersed in different concentrations of Spa33
(lacking a His6-tag) to monitor association and dissociation rates (see
Supplementary Materials). The KD was determined based on the
equilibrium reaction (Req) at different Spa33 concentrations. The KD value
was determined to be 0.55 ± 0.091 µM, which is in agreement with the
measured association and dissociation rates. The plotted data were
generated using GraphPad prism.June 2021 | Volume 11 | Article 682635
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however, structures available for FliN (Supplementary
Figure S3) and FliM (Supplementary Figure S14) from T.
maritima (Brown et al., 2005). We chose to use these as
surrogates for modeling the Spa33 heterotrimer into the pod
densities of the SP. FliM-FliN is a heterotetramer (Paul et al.,
2006) that has been proposed to be the structural equivalents of
the Spa33 heterotrimer. In such a model FliM would be
equivalent to the N-terminal portion of Spa33, despite there
likely being significant structural differences between them, and
the FliN trimer would represent the three copies of Spa33C
within the overall Spa33 complex (comprising two copies of
Spa33C with a third copy of the SPOA domain contributed by
one of the two tandem SPOA domains at the C-terminus of
Spa33FL). Using this and the flagellar C-ring of Vibrio
alginolyticus (Carroll et al., 2020) as a guide for generating a
model of the Spa33 heterotrimer and how such Spa33 complexes
might form an interface, we could insert two copies of the
modeled Spa33 homotrimer into a newly generated high-
resolution image of a single SP pod from the Shigella
injectisome (Figure 7). The fit appears to agree with the data
on the size and shape of wild-type Spa33 when it is alone and/or
incorporated into complexes with MxiN and MxiK (Table 3 and
Figures 7C, D).Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 11The proposed orientation of the Spa33 units in our model is
different from what is seen in the flagellar C-ring of V.
alginolyticus. Within the flagellar C-ring, multiple copies of the
FliM-FliN complex align side by side to generate a contiguous
ring (Figures 7E–G), however, the Spa33 heterotrimer could be
oriented differently so that it is nearly on its side to form a
complex with another Spa33 complex that lies above it
(Figures 7B, C). This would then give rise to six distinct pod
entities evenly placed around the central ATPase to which it is
connected via MxiN. Meanwhile, the upper Spa33 heterotrimer
may be shaped slightly differently in that it forms a tight complex
with MxiK whose density appears more globular than of MxiN in
the in situ SP (Figure 7D). The Spa33 component of the Spa33-
MxiK complex in this case could undergo a conformational
change as it interfaces with MxiK to give rise to a more compact
globular structure compared with the Spa33-MxiN complex.
This fits with the observation that the Dh of the Spa33-MxiK,
which is slightly smaller than that of the Spa33 heterotrimer
alone. The structure of SctK from P. aeruginosa is fit into the
density occupied by MxiK where it forms an intimate interface
with the upper Spa33 heterotrimer (Figures 7C, D and
Supplementary Figure S15). Thus, the Spa33 moiety within
the Spa33-MxiN and Spa33-MxiK complexes are proposed to
undergo conformational changes that give rise to two distinctFIGURE 7 | High-resolution structure and proposed model of the in situ SP pods from Shigella. (A) A cross-section image of the subtomogram average structure of
the injectisome shows (from top to bottom) the needle, basal body and SP. The two bacterial membranes are indicated by OM (the outer membrane) and CM (the
cytoplasmic membrane). The green arrow indicates the right side of the pod region that was used for the additional refinement process to improve its resolution.
(B) A 3D surface rendering image of the refined pod structure is shown. From the top down, the refined pod structure associates with the cytoplasmic domain of
MxiG (blue) and consists of MxiK (orange) and multiple copies of Spa33 (different shades of yellow), which also associate with MxiN (cyan at bottom) (Hu et al., 2015;
Tachiyama et al., 2019). The crystal structure of MxiK’s homologue from P. aeruginosa, SctK (Muthuramalingam et al., 2020) was fit into the density beneath MxiG
(right). Two copies of the Spa33 heterotrimer model were fit into the bottom part of Spa33 region in the refined pod structural image (right). Because this is a
preliminary model, some regions did not fit precisely into the cryo-ET image (see Supplementary Figure S15). The top of the proposed Spa33 density forms a
globular structure that interacts with MxiK. (C) The same images are shown rotated 90° relative to (B). This angle shows the single pod with a view that would be on
the inside of the SP cage. (D) The refined pod structure was fit back into a 3D surface rendering of the complete SP. This image shows the six pods forming the
cage-like structure of the SP. (E) A bottom view of a subtomogram average structure from the Vibrio alginolyticus flagella C-ring (Carroll et al., 2020). The C-ring is
composed FliM and FliN, which are homologous to Spa33 in the pod assembly. (F) A surface rendering of the C-ring with its 34-fold symmetry (EMDB-21837) was
generated using the UCSF Chimera (Pettersen et al., 2004) and ChimeraX (Goddard et al., 2018) software. (G) A side view of the 3D surface rendering of the C-ring
with a model of a full-length FliM (yellow) and three copies of FliN (green) from I-TASSER (Roy et al., 2010; Yang et al., 2015; Carroll et al., 2020) is shown. The red
arrow indicates a single unit of the C-ring structure for comparison with the refined single pod structure in (B, C).June 2021 | Volume 11 | Article 682635
Tachiyama et al. Shigella T3SS Sorting Platform Podscomplexes within the SP – one for interacting with the IR via
MxiGC and one for interacting with the Spa47 ATPase viaMxiN.DISCUSSION
This work provides a detailed biochemical and biophysical
exploration of the Shigella T3SS sorting platform (SP). The
component protein interactions described here have been
proposed before based on different types of analyses, including
two-hybrid analysis and pull-down assays (Jouihri et al., 2003;
Morita-Ishihara et al., 2006; Johnson and Blocker, 2008),
however, the data presented here and related cryo-ET studies
are making significant contributions to our detailed
understanding of the structures and interfaces that are
important for SP assembly (Hu et al., 2015; Hu et al., 2017).
The pods are the major component of the Shigella injectisome
SP. A difficulty encountered in focusing on these structures in
situ is their apparent flexibility and dynamics within the active
SP. Nevertheless, based on our findings, we can propose a model
for the assembly of the Spa33-containing pods and speculate as
to how these individual sub-assemblies contribute to active type
III secretion in Shigella. It is accepted that dynamic processes
within the SP are critical for recruitment of secretion substrates
to the injectisome and that the SctN ATPase has an essential role
in presenting these substrates to the export gate (Diepold et al.,
2017). As part of this process, SctN has been proposed to act as a
rotary motor (Majewski et al., 2019) in guiding substrates to the
export gate, perhaps via the central stalk formed by SctO (Spa13
in Shigella). Dielpold et al. reported that Yersinia SctQ, a Spa33
homologue, is present in more than 20 copies within the
injectisome SP and that it is in dynamic exchange with a
cytoplasmic population during active type III secretion
(Diepold et al., 2017). The details of how this dynamic
exchange occurs remains to be determined and how this
applies precisely to the Shigella system is far from clear.
It was recently reported by Bernal et al. that soluble
complexes consisting of the Salmonella SP components SctQFL,
SctQC, SctL and SctN could be assembled and the organization of
this complex could be determined using small-angle X-ray
scattering (SAXS) (Bernal et al., 2019). As with the Spa33
complex, SctQFL was made soluble by the presence of SctQC.
The SctQ heterotrimer could associate with a SctL dimer in
the same way that Spa33 and MxiN interact. They further
showed that the SctQ-SctL complex could associate with the
SctN ATPase. This is similar to the work of Notti et al. (2015)
who could purify a complex consisting of SctQ, SctL and
SctN. We did not attempt to generate a Spa33-MxiN-Spa47
complex, however, this is a relationship that will need to be
explored as this work continues. We also found that in addition
to MxiN, the Spa33 heterotrimer could associate with MxiK,
however, this required that the wild-type spa33 and mxiK be co-
expressed prior to purifying the resulting complex. This
association has a stabilizing (and solubilizing) effect on MxiK
and, based on the poor solubility of MxiK, it seems likely that the
MxiK that exists in the Shigella cytoplasm is in fact part of aFrontiers in Cellular and Infection Microbiology | www.frontiersin.org 12Spa33-MxiK complex that for the most part behaves as a single
folded unit that is highly stable. Moreover, the Spa33-MxiK
complex has biophysical properties (thermal stability and
hydrodynamic radius) that are distinct from those of the
Spa33-MxiN complex, which can be assembled in vitro from
purified components.
We have demonstrated that MxiK is an essential SP
component that acts as an adaptor between the SP and the
cytoplasmic domain of the IR protein MxiG. In the absence of
MxiK, the SP is completely absent from the injectisome.
Meanwhile, MxiN forms radial spokes that emanate from a
central hub that is the Spa47 hexamer (Hu et al., 2015). In the
absence of MxiN, remnants of the pods are still visible and these
are the result of the interactions between MxiG, MxiK and Spa33
(Supplementary Figure S2) (Hu et al., 2015). This unique
observation indicates that a sub-assembly consisting of MxiK
and Spa33 can be incorporated into an otherwise absent SP. That
cannot be said of MxiN-Spa33 subassemblies and this is why we
proposed that the Spa33-MxiK and Spa33-MxiN complexes can
form and behave independently in the Shigella cytoplasm.
Furthermore, it appears that the Spa33-MxiK units can be
associate with the injectisome basal body in the absence of
MxiN (Supplementary Figure S2).
From the data presented here and elsewhere, we propose that
the Spa33-MxiK and Spa33-MxiN assemblies are physiologically
relevant structures with important roles in the mechanisms
governing type III secretion in Shigella. These data are also
consistent with the large pod structures of the SP being formed
from two copies of the Spa33 heterotrimer with an architecture
that is altered from the interactions that give rise to a contiguous
flagellar C-ring. Thus, in view of the dynamics involving SctQ
exchange between the SP and cytoplasm, we propose a model in
which Spa33 heterotrimers act at two different locations during
the recruitment of secretion cargo. Spa33-MxiK complexes are
thus proposed to be required for communication between the
injectisome IR and the SP while Spa33-MxiN complexes are
active in ushering secretion substrates to the SP where they can
then be acted upon by Spa47 for chaperone removal and
presentation to the export gate (Akeda and Galan, 2005). It is
also possible that the Spa33-MxiN complex is interacting with
Spa47 prior to incorporation (with secretion substrate) into the
SP based on independent work by Notti et al. and Bernal et al.
(Notti et al., 2015; Bernal et al., 2019). The export gate then
harnesses the proton-motive forces to actually fuel the secretion
process (Shen and Blocker, 2016). It is also likely that the Spa33-
MxiK complex is in exchange with a cytoplasmic pool of similar
complexes. Interestingly, this complex has the potential to act
independent of the Spa33-MxiN complex in interacting with the
IR (Hu et al., 2015), perhaps to act in guiding Spa33-MxiN-
effector (and possibly Spa47) complexes to the SP where there are
up to five other pod complexes comprised of MxiK, Spa33 and
MxiN in association with the Spa47 hub. Such a model fits with
the cryo-ET based structural fits depicted in Figure 7, which are
modeled based on the similarities between the now solved
structure of Pseudomonas SctK and a model of the Spa33
heterotrimer based on similarities with the flagellar C-ringJune 2021 | Volume 11 | Article 682635
Tachiyama et al. Shigella T3SS Sorting Platform Podscomponents FliM and FliN (Supplementary Figure S15). The
model we propose here may be speculative, however, it does
appear that the densities beneath MxiK are sufficiently large to
accommodate two Spa33 heterotrimers. Ultimately, the ability to
precisely fit structures into these densities will require still higher
resolution cryo-ET structures and/or a high-resolution structure
(i.e crystal structure) of the Spa33 heterotrimer. Clearly, a great
deal of work remains to fully understand the events occurring
within the SP, however, complementary molecular, biophysical
and imaging techniques are beginning to shed light on how the
full injectisome functions. Perhaps further revelations will
become known when we are able to manipulate the Shigella
T3SS so that it adopts specific secretion states.DATA AVAILABILITY STATEMENT
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